recognized four sepsis phenotypes by using coagulopathy criteria andobserved that in patients with severe organ dysfunction and coagulopathy, theuse of thrombomodulin was associated with a lower mortality rate.(8). This evidence concerns the gene THBD and blood coagulation disease.